References
- Bagai A, Dangas GD, Stone GW, et al. Reperfusion strategies in acute coronary syndromes. Circ Res. 2014;114(12):1918-1928. doi: 10.1161/CIRCRESAHA.114.302744.
- Dubey G, Verma SK, Bahl VK. Primary percutaneous coronary intervention for acute ST elevation myocardial infarction: Outcomes and determinants of outcomes: A tertiary care center study from North India. Indian Heart J. 2017;69(3):294-298. doi: 10.1016/j.ihj.2016.11.322.
- Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361(9351):13-20. doi: 10.1016/S0140-6736(03)12113-7.
- van der Hoeven BL, Pires NM, Warda HM, et al. Drug-eluting stents: results, promises and problems. Int J Cardiol. 2005;99(1):9-17. doi: 10.1016/j.ijcard.2004.01.021.
- Konishi H, Miyauchi K, Dohi T, et al. Impact of stent length on clinical outcomes of first-generation and new-generation drug-eluting stents. Cardiovasc Interv Ther. 2016;31(2):114-21. doi: 10.1007/s12928-015-0362-0.
- Adnan Y, Noor L, Dar MH, et al. Impact of stent length and diameter on short term clinical outcomes of drug eluting stents in patients with stable coronary artery disease. Pak J Med Sci. 2017;33(4):959-962. doi: 10.12669/pjms.334.13068.
- Zbinden R, von Felten S, Wein B, et al. Impact of stent diameter and length on in-stent restenosis after DES vs BMS implantation in patients needing large coronary stents-A clinical and health-economic evaluation. Cardiovasc Ther. 2017;35(1):19-25. doi: 10.1111/1755-5922.12229.
- Otto CM. Textbook of Clinical Echocardiography. Elsevier Health Sciences; 2013 Apr 25.
- Kjøller-Hansen L, Kelbæk H, Christiansen E, et al. Predictors of 10-Year Stent-Related Adverse Outcomes after Coronary Drug-Eluting Stent Implantation: The Importance of Stent Size. Cardiology. 2021;146:1-8. doi: 10.1159/000517614.
- Maruszak N, Pilch W, Januszek R, et al. Risk factors of suboptimal coronary blood flow after a percutaneous coronary intervention in patients with acute anterior wall myocardial infarction. J Pers Med. 2023;13(8):1217. doi: 10.3390/jpm13081217.
- Kumar V, Sharma AK, Kumar T, et al. Large intracoronary thrombus and its management during primary PCI. Indian Heart J. 2020;72(6):508-516. doi: 10.1016/j.ihj.2020.11.009.
- Kim YH, Her AY, Jeong MH, et al. Comparison of first-and second-generation drug-eluting stents in patients with ST-segment elevation myocardial infarction based on pre-percutaneous coronary intervention thrombolysis in myocardial infarction flow grade. J Clin Med. 2021;10(2):367. doi: 10.1016/j.ihj.2020.11.009.
- Geyer M, Wild J, Hirschmann M, Dimitriadis Z, Münzel T, Gori T, Wenzel P. Predictors for target vessel failure after recanalization of chronic total occlusions in patients undergoing surveillance coronary angiography. J Clin Med. 2020 Jan 9;9(1):178.
- Kim YH, Her AY, Jeong MH, et al. Effects of stent generation on clinical outcomes after acute myocardial infarction compared between prediabetes and diabetes patients. Sci Rep. 2021;11(1):9364. doi: 10.1016/j.ihj.2020.11.009.
- Roffi M, Patrono C, Collet JP, et al; ESC Scientific Document Group. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(3):267-315. doi: 10.1016/j.ihj.2020.11.009.
- Chen Y, Gao YF, Wang YF, et al. Influence of stent length on periprocedural outcomes after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Clin Interv Aging. 2022;17:1687-1695. doi: 10.2147/cia.s389302.
- El-Rabat K, Hamouda M, El-Nagar A, et al. Clinical and angiographic predictors of no-reflow phenomenon during primary percutaneous coronary intervention. Benha J Appl Sci. 2021;6(1):267-272. doi: 10.21608/BJAS.2021.169124.
- Alidoosti M, Lotfi R, Lotfi-Tokaldany M, et al. Correlates of the “no-reflow” or “slow-flow” phenomenon in patients undergoing primary percutaneous coronary intervention. J Tehran Heart Cent. 2018;13(3):108-114. doi: 10.21608/BJAS.2021.169124.
- Bauer D, Toušek P. Risk stratification of patients with acute coronary syndrome. J Clin Med. 2021;10(19). doi: 10.3390/jcm10194574.
- Yu Y, Wu Y, Wu X, et al. Risk factors for no-reflow in patients with ST-elevation myocardial infarction who underwent percutaneous coronary intervention: a case-control study. Cardiol Res Pract. 2022;2022:3482518. doi: 10.1155/2022/3482518.
- Zhou H, He XY, Zhuang SW, et al. Clinical and procedural predictors of no-reflow in patients with acute myocardial infarction after primary percutaneous coronary intervention. World J Emerg Med. 2014;5(2):96. doi: 10.5847/wjem.j.issn.1920-8642.2014.02.003.
- Ejiri K, Sawano M, Numasawa Y, et al. Association of second-generation drug-eluting stent length with 2-year adverse clinical outcomes among Japanese patients with ischemic heart disease. JAMA Netw Open. 2020;3(8). doi: 10.5847/wjem.j.issn.1920-8642.2014.02.003.
- Adnan Y, Noor L, Dar MH, et al. Impact of stent length and diameter on short term clinical outcomes of drug eluting stents in patients with stable coronary artery disease. Pak J Med Sci. 2017;33(4):959. doi: 10.5847/wjem. j.issn.1920-8642.2014.02.003.